Malawani, Laila S.
HRN: 10-00-89 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/19/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/19/2023
10/26/2023
IV
500mg
Q8
Amoebiasis
Checking Final Appropriateness